It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Over the past two decades, studies on the cellular response to very low dose radiation have been revolutionizing historically-held paradigms of cellular radioresponse. Indeed, a host of seemingly contradictory events have recently been reported to occur within this dose range of radiation exposure which make extrapolation of data derived from high dose studies to these low dose ranges no longer a feasible alternative. In this study, we investigate the radioresponse of two human tumor cell lines, A375 human melanoma cells and PC3 human prostate cancer cells, which appear to behave quite differently in the very low dose radiation range. More specifically, we (a) characterize the cell survival response following low dose radiation in the A375 human melanoma cells and PC3 human prostate cancer cell lines; (b) investigate the kinetics and magnitude of cell cycle arrest that occurs following low dose radiation exposure in these cell lines; and (c) ascertain whether signaling through the MAPK and NF-κB proliferative pathways is being stimulated following exposure to low doses of radiation. The results of these studies demonstrate that two different and contradictory survival responses are seen following exposure to very low dose irradiation (hyper-radioresistance in A375 cells vs. hyper-radiosensitivity in PC3 cells). Furthermore, the data indicate that differential regulation of G2/M cell cycle arrest may be involved in the contradictory survival responses observed.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer





